综述 |
|
|
|
|
降血糖药对内皮祖细胞作用的研究进展 |
韩雪1,2( ),蒋国军2,石巧娟1,*( ) |
1. 杭州医学院实验动物中心, 浙江 杭州 310015 2. 浙江萧山医院药剂科, 浙江 杭州 311200 |
|
Effects of antihyperglycemics on endothelial progenitor cells |
HAN Xue1,2( ),JIANG Guojun2,SHI Qiaojuan1,*( ) |
1. Laboratory Animal Center, Hangzhou Medical College, Hangzhou 310015, China 2. Department of Pharmacy, Zhejiang Xiaoshan Hospital, Hangzhou 311200, China |
1 |
RIDDY D M , DELERIVE P , SUMMERS R J et al. G Protein-coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus[J]. Pharmacol Rev, 2018, 70 (1): 39- 67
doi: 10.1124/pr.117.014373
|
2 |
SHAN K , LIU C , LIU B H et al. Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus[J]. Circulation, 2017, 136 (17): 1629- 1642
doi: 10.1161/CIRCULATIONAHA.117.029004
|
3 |
DAI X, YAN X, ZENG J, et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3β/Fyn-mediated Nrf2 activation in diabetic limb ischemia[J/OL]. Circ Res, 2017, 120(5): e7-e23. DOI: 10.1161/CIRCRESAHA.117.310619.
|
4 |
CHOI J H , NGUYEN M P , JUNG S Y et al. Inhibitory effect of glyceollins on vasculogenesis through suppression of endothelial progenitor cell function[J]. Mol Nutr Food Res, 2013, 57 (10): 1762- 1771
doi: 10.1002/mnfr.201200826
|
5 |
ITO C , KUMAGAI M , MANABE A et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes:a distinct biological entity with a marked propensity to undergo apoptosis[J]. Blood, 1999, 93 (1): 315- 320
doi: 10.1182/blood.V93.1.315
|
6 |
HILL J M , ZALOS G , HALCOX J P et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk[J]. N Engl J Med, 2003, 348 (7): 593- 600
doi: 10.1056/NEJMoa022287
|
7 |
HRISTOV M , ERL W , WEBER P C . Endothelial progenitor cells:isolation and characterization[J]. Trends Cardiovasc Med, 2003, 13 (5): 201- 206
doi: 10.1016/s1050-1738(03)00077-x
|
8 |
MCCLOSKEY K E , SMITH D A , JO H et al. Embryonic stem cell-derived endothelial cells may lack complete functional maturation in vitro[J]. J Vasc Res, 2006, 43 (5): 411- 421
doi: 10.1159/000094791
|
9 |
GLASER R , PEACOCK W F , WU A H et al. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers[ARROW]) study[J]. Am J Cardiol, 2011, 107 (6): 821- 826
doi: 10.1016/j.amjcard.2010.11.003
|
10 |
MUROHARA T , IKEDA H , DUAN J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization[J]. J Clin Invest, 2000, 105 (11): 1527- 1536
doi: 10.1172/JCI8296
|
11 |
BAGLEY R G , WALTER-YOHRLING J , CAO X et al. Endothelial precursor cells as a model of tumor endothelium:characterization and comparison with mature endothelial cells[J]. Cancer Res, 2003, 63 (18): 5866- 5873
|
12 |
THUM T , FRACCAROLLO D , SCHULTHEISS M et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes[J]. Diabetes, 2007, 56 (3): 666- 674
doi: 10.2337/db06-0699
|
13 |
SCHALKWIJK C G , STEHOUWER C D . Vascular complications in diabetes mellitus:the role of endothelial dysfunction[J]. Clin Sci (Lond), 2005, 109 (2): 143- 159
doi: 10.1042/CS20050025
|
14 |
FADINI G P , SARTORE S , ALBIERO M et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy[J]. Arterioscler Thromb Vasc Biol, 2006, 26 (9): 2140- 2146
doi: 10.1161/01.ATV.0000237750.44469.88
|
15 |
YU J W , DENG Y P , HAN X et al. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice[J]. Cardiovasc Diabetol, 2016, 15 88
doi: 10.1186/s12933-016-0408-3
|
16 |
HAN X , TAO Y , DENG Y et al. Metformin accelerates wound healing in type 2 diabetic db/db mice[J]. Mol Med Rep, 2017, 16 (6): 8691- 8698
doi: 10.3892/mmr.2017.7707
|
17 |
SPIGONI V, PICCONI A, CITO M, et al. Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance[J/OL]. PLoS One, 2012, 7(11): e48283. DOI: 10.1371/journal.pone.0048283.
|
18 |
HAN X , DENG Y , YU J et al. Acarbose accelerates wound healing via Akt/eNOS signaling in db/db Mice[J]. Oxid Med Cell Longev, 2017, 2017 7809581
doi: 10.1155/2017/7809581
|
19 |
DONG L , KANG L , DING L et al. Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice[J]. Microvasc Res, 2011, 82 (3): 227- 236
doi: 10.1016/j.mvr.2011.09.006
|
20 |
ZHANG H F , WANG L , YUAN H J et al. PPAR-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow[J]. Cell Biol Int, 2013, 37 (5): 430- 435
doi: 10.1002/cbin.10046
|
21 |
GHOSH S , LAKSHMANAN A P , HWANG M J et al. Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions[J]. Biochem Pharmacol, 2015, 98 (3): 412- 421
doi: 10.1016/j.bcp.2015.10.008
|
22 |
HATTORI Y , HATTORI K , HAYASHI T . Pleiotropic benefits of metformin:macrophage targeting its anti-inflammatory mechanisms[J]. Diabetes, 2015, 64 (6): 1907- 1909
doi: 10.2337/db15-0090
|
23 |
LIAO Y F , CHEN L L , ZENG T S et al. Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes[J]. Vasc Med, 2010, 15 (4): 279- 285
doi: 10.1177/1358863X10367537
|
24 |
CHEN L L , LIAO Y F , ZENG T S et al. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients[J]. Endocrine, 2010, 38 (2): 266- 275
doi: 10.1007/s12020-010-9383-8
|
25 |
AMBASTA R K , KOHLI H , KUMAR P . Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder[J]. J Transl Med, 2017, 15 (1): 185
doi: 10.1186/s12967-017-1280-y
|
26 |
WU N , GU H J , LI Q . Effects of antidiabetic drug metformin on the migration and invasion abilities of human pulmonary adenocarcinoma A549 cell line in vitro[J]. J Thorac Dis, 2010, 2 (2): 76- 80
|
27 |
CHEN X , HU C , ZHANG W et al. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro[J]. Tumour Biol, 2015, 36 (12): 9873- 9883
doi: 10.1007/s13277-015-3751-1
|
28 |
DORMANDY J A , CHARBONNEL B , ECKLAND D J et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):a randomised controlled trial[J]. Lancet, 2005, 366 (9493): 1279- 1289
doi: 10.1016/S0140-6736(05)67528-9
|
29 |
RUIZ E , REDONDO S , GORDILLO-MOSCOSO A et al. EPCs adhesion to arteries from diabetic and non-diabetic patients:effect of pioglitazone[J]. Front Biosci (Landmark Ed), 2009, 14 (1): 3608- 3618
doi: 10.2741/3475
|
30 |
WANG C H, TING M K, VERMA S, et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus[J/OL]. Am Heart J, 2006, 152(6): 1051.e1-e8. DOI: 10.1016/j.ahj.2006.07.029.
|
31 |
MINAMINO T , MIYAUCHI H , YOSHIDA T et al. Endothelial cell senescence in human atherosclerosis:role of telomere in endothelial dysfunction[J]. Circulation, 2002, 105 (13): 1541- 1544
doi: 10.1161/01.cir.0000013836.85741.17
|
32 |
VAN DER HARST P , VAN DER STEEGE G , DE BOER R A et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure[J]. J Am Coll Cardiol, 2007, 49 (13): 1459- 1464
doi: 10.1016/j.jacc.2007.01.027
|
33 |
MINAMINO T , KOMURO I . Role of telomeres in vascular senescence[J]. Front Biosci, 2008, 13 2971- 2979
doi: 10.2741/2902
|
34 |
ASSMUS B , URBICH C , AICHER A et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes[J]. Circ Res, 2003, 92 (9): 1049- 1055
doi: 10.1161/01.RES.0000070067.64040.7C
|
35 |
RUDOLPH K L , CHANG S , LEE H W et al. Longevity, stress response, and cancer in aging telomerase-deficient mice[J]. Cell, 1999, 96 (5): 701- 712
doi: 10.1016/s0092-8674(00)80580-2
|
36 |
IMANISHI T , HANO T , SAWAMURA T et al. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction[J]. Clin Exp Pharmacol Physiol, 2004, 31 (7): 407- 413
doi: 10.1111/j.1440-1681.2004.04022.x
|
37 |
KURZ D J , DECARY S , HONG Y et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells[J]. J Cell Sci, 2004, 117 (Pt 11): 2417- 2426
doi: 10.1242/jcs.01097
|
38 |
FUJII H , LI S H , SZMITKO P E et al. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells[J]. Arterioscler Thromb Vasc Biol, 2006, 26 (11): 2476- 2482
doi: 10.1161/01.ATV.0000242794.65541.02
|
39 |
MURASAWA S , LLEVADOT J , SILVER M et al. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells[J]. Circulation, 2002, 106 (9): 1133- 1139
doi: 10.1161/01.cir.0000027584.85865.b4
|
40 |
IMANISHI T , KOBAYASHI K , KUROI A et al. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell[J]. Hypertens Res, 2008, 31 (4): 757- 765
doi: 10.1291/hypres.31.757
|
41 |
ZHENG M Y , YANG J H , SHAN C Y et al. Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients:a preliminary report[J]. Cardiovasc Diabetol, 2013, 12 73
doi: 10.1186/1475-2840-12-73
|
42 |
NAKAMURA K , OE H , KIHARA H et al. DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes:EDGE study[J]. Cardiovasc Diabetol, 2014, 13 110
doi: 10.1186/s12933-014-0110-2
|
43 |
KEATING G M . Vildagliptin:a review of its use in type 2 diabetes mellitus[J]. Drugs, 2010, 70 (16): 2089- 2112
doi: 10.2165/11206370-000000000-00000
|
44 |
FADINI G P , BOSCARO E , ALBIERO M et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes:possible role of stromal-derived factor-1alpha[J]. Diabetes Care, 2010, 33 (7): 1607- 1609
doi: 10.2337/dc10-0187
|
45 |
ASO Y , JOJIMA T , IIJIMA T et al. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+ CXCR4+ cells in patients with type 2 diabetes[J]. Endocrine, 2015, 50 (3): 659- 664
doi: 10.1007/s12020-015-0688-5
|
46 |
DEI CAS A , SPIGONI V , CITO M et al. Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number:a 12-month randomized controlled trial in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2017, 16 (1): 27
doi: 10.1186/s12933-017-0503-0
|
47 |
FADINI G P , BONORA B M , CAPPELLARI R et al. Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes[J]. J Clin Endocrinol Metab, 2016, 101 (2): 748- 756
doi: 10.1210/jc.2015-3716
|
48 |
FADINI G P , DE KREUTZENBERG S V , MARIANO V et al. Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy:a randomized crossover trial comparing detemir versus glargine[J]. Diabetes Obes Metab, 2011, 13 (8): 718- 725
doi: 10.1111/j.1463-1326.2011.01396.x
|
49 |
OIKONOMOU D , KOPF S , VON BAUER R et al. Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients:a partially double-blind, randomized, three-arm unicenter study[J]. Cardiovasc Diabetol, 2014, 13 137
doi: 10.1186/s12933-014-0137-4
|
50 |
HUMPERT P M , NEUWIRTH R , BATTISTA M J et al. SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes[J]. Diabetes Care, 2005, 28 (4): 934- 936
doi: 10.2337/diacare.28.4.934
|
51 |
杨吉锋, 陶松桔, 张亚萍 et al. 短期胰岛素泵强化治疗对初诊T2DM患者循环内皮祖细胞水平的影响及其抗炎机制[J]. 中国临床研究, 2011, 24 (8): 666- 668 YANG Jifeng , TAO Songju , ZHANG Yaping et al. Effect of short-term intensive treatment with insulin pump on the level of circulating endothelial progenitor cells in patients with newly diagnosed type 2 diabetes and its anti-inflammatory mechanism[J]. Chinese Journal of Clinical Research, 2011, 24 (8): 666- 668
|
52 |
CHEN Y , ZHANG X , HE J et al. Delayed administration of the glucagon-like peptide 1 analog liraglutide promoting angiogenesis after focal cerebral ischemia in mice[J]. J Stroke Cerebrovasc Dis, 2018, 27 (5): 1318- 1325
doi: 10.1016/j.jstrokecerebrovasdis.2017.12.015
|
53 |
ZITMAN-GAL T , EINBINDER Y , OHANA M et al. Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells[J]. J Diabetes, 2019, 11 (8): 656- 664
doi: 10.1111/1753-0407.12891
|
54 |
李彩林, 雅军, 郭立新 . 利拉鲁肽对瘦素受体缺陷大鼠主动脉内皮细胞的保护作用及机制[J]. 中华糖尿病杂志, 2017, 9 (9): 567- 572 LI Cailin , YA Jun , GUO Lixin . Protective effect and mechanism of liraglutide on aorta endothelial cells in Zucker diabetic fatty rats[J]. Chinese Journal of Diabetes Mellitus, 2017, 9 (9): 567- 572
doi: 10.3760/cma.j.issn.1674-5809.2017.09.007
|
55 |
李虎, 束庆, 杨贤 et al. 利拉鲁肽对高糖诱导的人脐静脉内皮细胞与单核细胞黏附的影响及作用机制[J]. 中国医师杂志, 2019, 21 (6): 830- 834, 839 LI Hu , SHU Qing , YANG Xian et al. Liraglutide prevents high glucose-induced adhesion of endothelial cells to monocyte by targeting IKK-NF-κB[J]. Journal of Chinese Physician, 2019, 21 (6): 830- 834, 839
doi: 10.3760/cma.j.issn.1008-1372.2019.06.008
|
56 |
DALAMA B , MESA J . New oral hypoglycemic agents and cardiovascular risk. Crossing the metabolic border[J]. Rev Esp Cardiol (Engl Ed), 2017, 70 (4): 309
doi: 10.1016/j.rec.2016.11.034
|
57 |
SCHNELL O, VALENSI P, STANDL E, et al. Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes[J/OL]. Endocrinol Diabetes Metab, 2020, 3(3): e00129. DOI: 10.1002/edm2.129.
|
58 |
GASPARI T , SPIZZO I , LIU H et al. Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation:a potential mechanism for inhibition of atherogenesis[J]. Diab Vasc Dis Res, 2018, 15 (1): 64- 73
doi: 10.1177/1479164117733626
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|